NYT

The New York Times Company NYSE

Communication Services ·Publishing ·US · nytco.com

$77.26

Mkt Cap $12.5B

52w Low $51.03 72.7% of range 52w High $87.10

50d MA $80.77 200d MA $67.14

P/E (TTM) 37.3x

EV/EBITDA 20.7x

P/B 6.3x

Debt/Equity 0.0x

ROE 16.9%

P/FCF 20.6x

RSI (14) —

ATR (14) —

Beta 1.05

50d MA $80.77

200d MA $67.14

Avg Volume 2.5M

About

The New York Times Company, together with its subsidiaries, provides news and information for readers and viewers across various platforms worldwide. It offers The New York Times (The Times), a daily and Sunday newspaper in the United States, as well as international edition of The Times; and operates the NYTimes.com Website. The company also transmits articles, graphics, and photographs from The …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 4, 2026	AMC	0.88	0.89	+1.1%	67.63	-0.1%	+2.2%	+0.7%	+1.5%	+4.6%	+5.5%	—
Nov 5, 2025	AMC	0.53	0.59	+10.7%	57.61	+0.7%	+4.1%	+6.5%	+8.6%	+9.4%	+9.8%	—
Aug 6, 2025	AMC	0.50	0.58	+16.0%	61.95	+0.1%	-6.1%	-7.2%	-7.0%	-6.4%	-2.1%	—
May 7, 2025	AMC	0.35	0.41	+17.1%	52.64	+0.7%	-0.1%	+1.8%	+3.0%	+3.9%	+4.6%	—
Feb 5, 2025	AMC	0.74	0.80	+8.1%	49.23	+0.9%	-0.1%	-0.8%	+0.1%	+0.7%	+2.4%	—
Nov 4, 2024	AMC	0.41	0.45	+9.8%	52.45	+1.1%	+1.5%	+6.7%	+6.4%	+7.3%	+4.6%	—
Aug 7, 2024	AMC	0.40	0.45	+12.5%	53.92	+2.1%	-0.4%	+0.1%	-0.2%	+1.2%	+1.2%	—
May 8, 2024	AMC	0.20	0.31	+55.0%	47.74	+0.9%	+0.5%	+0.5%	+0.6%	+0.7%	+0.4%	—
Feb 7, 2024	AMC	0.58	0.70	+20.7%	44.96	-0.4%	-2.7%	-2.4%	-1.5%	-1.8%	-1.7%	—
Nov 8, 2023	AMC	0.29	0.37	+27.6%	44.12	+0.7%	-2.3%	-1.2%	-1.6%	+0.5%	+0.5%	—
Aug 8, 2023	AMC	0.21	0.38	+81.0%	44.29	-0.2%	-0.9%	-0.4%	+0.1%	-0.6%	-3.0%	—
May 10, 2023	AMC	0.16	0.19	+18.8%	36.14	-0.8%	+0.1%	+1.5%	+1.4%	+0.1%	+1.5%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 22	BofA Securities	Initiates	Neutral	$84	$81.62	$81.84	+0.3%	-1.4%	-1.5%	-0.9%	-2.5%	-3.9%
Mar 24	Citigroup	Maintains	Buy → Buy	—	$82.69	$83.03	+0.4%	+1.8%	+3.0%	+0.3%	+0.1%	+0.7%
Feb 5	Evercore ISI	Maintains	Outperform → Outperform	—	$67.63	$67.56	-0.1%	+2.2%	+0.7%	+1.5%	+4.6%	+5.5%
Feb 5	JP Morgan	Maintains	Overweight → Overweight	—	$67.63	$67.56	-0.1%	+2.2%	+0.7%	+1.5%	+4.6%	+5.5%
Feb 5	Citigroup	Maintains	Buy → Buy	—	$67.63	$67.56	-0.1%	+2.2%	+0.7%	+1.5%	+4.6%	+5.5%
Jan 20	Barclays	Maintains	Equal Weight → Equal Weight	—	$71.49	$71.63	+0.2%	-1.7%	-0.8%	-0.3%	+1.1%	+1.9%
Dec 23	Citigroup	Maintains	Buy → Buy	—	$70.52	$70.71	+0.3%	+0.3%	+0.7%	-0.5%	-1.4%	-1.1%
Nov 13	Citigroup	Maintains	Buy → Buy	—	$63.25	$63.50	+0.4%	+2.0%	+1.1%	-0.4%	+1.2%	+0.8%
Nov 6	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$57.61	$58.00	+0.7%	+4.1%	+6.5%	+8.6%	+9.4%	+9.8%
Nov 6	JP Morgan	Maintains	Overweight → Overweight	—	$57.61	$58.00	+0.7%	+4.1%	+6.5%	+8.6%	+9.4%	+9.8%
Nov 6	Barclays	Maintains	Equal Weight → Equal Weight	—	$57.61	$58.00	+0.7%	+4.1%	+6.5%	+8.6%	+9.4%	+9.8%
Aug 8	Evercore ISI	Maintains	Outperform → Outperform	—	$58.19	$58.32	+0.2%	-1.2%	-1.0%	-0.3%	+4.2%	+3.3%
Aug 7	Barclays	Maintains	Equal Weight → Equal Weight	—	$61.95	$62.00	+0.1%	-6.1%	-7.2%	-7.0%	-6.4%	-2.1%
Aug 7	Guggenheim	Maintains	Neutral → Neutral	—	$61.95	$62.00	+0.1%	-6.1%	-7.2%	-7.0%	-6.4%	-2.1%
Aug 7	JP Morgan	Maintains	Overweight → Overweight	—	$61.95	$62.00	+0.1%	-6.1%	-7.2%	-7.0%	-6.4%	-2.1%
Aug 7	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$61.95	$62.00	+0.1%	-6.1%	-7.2%	-7.0%	-6.4%	-2.1%
Jun 2	Guggenheim	Maintains	Neutral → Neutral	—	$57.12	$56.88	-0.4%	-0.2%	-1.9%	-2.3%	-2.4%	-2.3%
May 8	Guggenheim	Maintains	Neutral → Neutral	—	$52.64	$53.03	+0.7%	-0.1%	+1.8%	+3.0%	+3.9%	+4.6%
Feb 6	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$49.23	$49.65	+0.9%	-0.1%	-0.8%	+0.1%	+0.7%	+2.4%
Nov 5	JP Morgan	Maintains	Overweight → Overweight	—	$52.45	$53.04	+1.1%	+1.5%	+6.7%	+6.4%	+7.3%	+4.6%
Nov 5	Deutsche Bank	Maintains	Buy → Buy	—	$52.45	$53.04	+1.1%	+1.5%	+6.7%	+6.4%	+7.3%	+4.6%
Aug 8	Barclays	Maintains	Equal Weight → Equal Weight	—	$53.92	$55.07	+2.1%	-0.4%	+0.1%	-0.2%	+1.2%	+1.2%
Aug 8	JP Morgan	Maintains	Overweight → Overweight	—	$53.92	$55.07	+2.1%	-0.4%	+0.1%	-0.2%	+1.2%	+1.2%
May 9	Evercore ISI	Maintains	Outperform → Outperform	—	$47.74	$48.18	+0.9%	+0.5%	+0.5%	+0.6%	+0.7%	+0.4%
Nov 9	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$44.12	$44.41	+0.7%	-2.3%	-1.2%	-1.6%	+0.5%	+0.5%
Aug 10	Guggenheim	Maintains	Neutral → Neutral	—	$43.89	$44.14	+0.6%	+0.5%	+1.0%	+0.3%	-2.1%	-3.0%
Aug 9	JP Morgan	Maintains	Overweight → Overweight	—	$44.29	$44.20	-0.2%	-0.9%	-0.4%	+0.1%	-0.6%	-3.0%
Aug 9	Barclays	Maintains	Equal Weight → Equal Weight	—	$44.29	$44.20	-0.2%	-0.9%	-0.4%	+0.1%	-0.6%	-3.0%
Aug 9	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$44.29	$44.20	-0.2%	-0.9%	-0.4%	+0.1%	-0.6%	-3.0%
Jul 12	Barclays	Maintains	Equal Weight → Equal Weight	—	$41.53	$42.06	+1.3%	+1.1%	+0.7%	-0.1%	-0.1%	+2.6%
May 12	Barclays	Maintains	Equal Weight → Equal Weight	—	$36.18	$36.34	+0.4%	+1.4%	+1.3%	-0.1%	+1.4%	+0.8%
Mar 15	JP Morgan	Maintains	Overweight → Overweight	—	$36.17	$36.00	-0.5%	+1.0%	+2.4%	+1.9%	+4.8%	+7.2%
Feb 9	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$41.13	$41.75	+1.5%	-2.5%	-4.0%	-4.2%	-3.0%	-3.1%
Feb 9	Barclays	Upgrade	Underweight → Equal Weight	—	$41.13	$41.75	+1.5%	-2.5%	-4.0%	-4.2%	-3.0%	-3.1%
Dec 16	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$33.46	$33.00	-1.4%	-3.1%	-4.2%	-3.4%	-3.1%	-2.4%
Sep 2	Cannonball Research	Downgrade	Buy → Neutral	—	$30.97	$31.34	+1.2%	-1.0%	-4.0%	-1.7%	-1.3%	+2.6%
Aug 4	Morgan Stanley	Maintains	Overweight → Overweight	—	$30.81	$30.24	-1.9%	+0.1%	+0.6%	+0.5%	-0.7%	+2.9%
Jul 21	Guggenheim	Maintains	Neutral → Neutral	—	$30.82	$30.40	-1.4%	-0.2%	+0.6%	-0.1%	-3.4%	+2.5%
Jun 22	Cannonball Research	Downgrade	Buy → Neutral	—	$29.09	$28.43	-2.3%	-2.9%	+0.6%	+2.0%	+1.6%	-1.9%
Jun 21	Evercore ISI	Maintains	Outperform → Outperform	—	$29.70	$29.78	+0.3%	-2.1%	-4.9%	-1.4%	-0.1%	-0.5%
Jun 14	Barclays	Maintains	Underweight → Underweight	—	$28.99	$28.68	-1.1%	-0.9%	+3.6%	+1.6%	+2.4%	+0.3%
Jun 14	Morgan Stanley	Maintains	Overweight → Overweight	—	$28.99	$28.68	-1.1%	-0.9%	+3.6%	+1.6%	+2.4%	+0.3%
Jun 14	JP Morgan	Maintains	Overweight → Overweight	—	$28.99	$28.68	-1.1%	-0.9%	+3.6%	+1.6%	+2.4%	+0.3%
Dec 6	Wolfe Research	Downgrade	Outperform → Peer Perform	—	$47.47	$45.51	-4.1%	-1.9%	-2.3%	-1.4%	-4.3%	-5.3%
Nov 2	Morgan Stanley	Maintains	Overweight → Overweight	—	$55.03	$55.53	+0.9%	+1.4%	-8.3%	-6.9%	-8.9%	-10.1%
Feb 5	Morgan Stanley	Maintains	Overweight → Overweight	—	$51.68	$51.38	-0.6%	-1.7%	-2.1%	-3.8%	-4.8%	-4.3%
Nov 9	Evercore ISI	Upgrade	In Line → Outperform	—	$39.56	$40.82	+3.2%	-1.7%	-3.2%	-2.6%	-1.8%	+0.5%
Oct 14	Morgan Stanley	Maintains	Overweight → Overweight	—	$43.35	$43.96	+1.4%	+4.2%	+5.1%	+1.6%	+1.1%	-0.2%
Aug 27	Wolfe Research	Maintains	Outperform → Outperform	—	$43.15	$43.65	+1.2%	+0.5%	+1.5%	+0.4%	+1.3%	+1.2%
Jun 15	JP Morgan	Maintains	Overweight → Overweight	—	$40.56	$40.09	-1.2%	+3.0%	+3.5%	+5.5%	+4.9%	+3.3%

Recent Filings

SC TO-I !!! Very High

Robin Energy Ltd. -- Issuer Tender Offer

Robin Energy Ltd. is conducting a tender offer at $3.00 per share, allowing investors to sell shares back to the company at a predetermined price.

Apr 27

8-K

New York Times Co. -- 8-K Filing

New York Times shareholders overwhelmingly approved a proposal with 754,431 votes in favor and virtually no opposition, indicating strong investor confidence in management's direction.

Apr 23

8-K

New York Times Co. -- 8-K Filing

New York Times added 450,000 digital subscribers in Q4 2025, reaching 12.78 million total subscribers, demonstrating continued momentum in its core subscription business strategy.

Feb 4

SC TO-T !!! Very High

Applied Therapeutics, Inc. -- Tender Offer

Applied Therapeutics shareholders will have the opportunity to sell their shares through a tender offer, though the filing doesn't specify the offer price or bidder identity.

Feb 3

Data updated apr 26, 2026 4:41pm · Source: massive.com